Not provided
Not provided
Not provided
Not provided
Not provided
Low participant number.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Background:
Despite an increase in lifespan over the last decades, our healthspan lags behind. In our aging population, it is pressing that we prevent age-related morbidities and associated burden on the health care system. Instead of investigating aging in already aged populations, the currently proposed study aims to elucidate the process of immune aging in relation to biological aging, demographic and lifestyle factors in young and midlife adults, and to identify early biomarkers and pathways associated with fast versus slow immune aging and aging endotypes.
Study design:
A single-center, observational prospective cohort study in the Netherlands. Participants from priorly established cohorts will be invited to join the EVIA-study. We will obtain demographic and basic clinical data and biological samples (blood and stool) at baseline and after three years, with a short, yearly online questionnaire in between.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 20-30 years old | The target population consists of 1000 participants, equally distributed over different age groups (20-30, 30-40, 40-50, and 50-60 years old) and sex. Main exclusion criteria are any systemic condition or medication apart from cardiometabolic disorders, pregnancy at inclusion or recent vaccinations. Individuals will be compared over time, and age groups will be compared over time and per time point. None of the age groups will get an intervention, the goal is to observationally study them. |
| |
| 3-40 years old | The target population consists of 1000 participants, equally distributed over different age groups (20-30, 30-40, 40-50, and 50-60 years old) and sex. Main exclusion criteria are any systemic condition or medication apart from cardiometabolic disorders, pregnancy at inclusion or recent vaccinations. Individuals will be compared over time, and age groups will be compared over time and per time point. None of the age groups will get an intervention, the goal is to observationally study them. |
| |
| 40-50 years old | The target population consists of 1000 participants, equally distributed over different age groups (20-30, 30-40, 40-50, and 50-60 years old) and sex. Main exclusion criteria are any systemic condition or medication apart from cardiometabolic disorders, pregnancy at inclusion or recent vaccinations. Individuals will be compared over time, and age groups will be compared over time and per time point. None of the age groups will get an intervention, the goal is to observationally study them. |
| |
| 50-60 years old |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No intervention, we just study 'aging' | Other | No intervention, we just study 'aging' |
|
| Measure | Description | Time Frame |
|---|---|---|
| Immunological function | As comprised by cytokine porudction capacity, immunophenotyping, circulating inflammatory markers and metabolomics | At baseline and after 3 years |
| Immunological Aging Score | As scored by immune population aging scores, an inflammatory aging score (unpiblished work) and a transcriptomics aging score (idem) | At baseline and after 3 years |
| Biological Aging Score | As scored by epigenetic aging (scored by means of DNA methylation), organ aging (Oh et al) and lipidomic aging scores (unpublished) | At baseline and after 3 years |
| Metagenomics | From stool microbiome | At baseline and after 3 years |
| Genetics and epigenetics | SNPs, telomere attrition, accessible loci | At baseline and after 3 years |
| Clinical events | Hospital admissions and new medical diagnoses | Between baseline and the 3-year timepoint |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Any systemic disease or condition, or the use of systemic medication, with the exception of the following:
Pregnancy at inclusion (will be recorded during study);
Acute illness or fever <1 month before inclusion;
Received vaccines or antibiotics 3 months before inclusion;
Participation in an intervention trial;
Legally incapacitated or unwilling to provide informed consent.
Not provided
Not provided
Participants for each age group will be recruited via invitation. Former participants from the HFGP cohorts will be invited only if they had originally given permission to be approached for future studies. In case insufficient inclusions result from previous cohorts, we will proceed to recruit new healthy volunteers from the Nijmegen region. In that case, we will promote the study via local newspaper(s), social media, and flyers (will be added to the CMO file should this arise). This way, the recruitment is performed as an open invitation, and any willing participants may reach out to the research team via email or telephone.
This is an observational study to explore natural aging. Participants are not subjected to any intervention.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Radboud university medical center | Nijmegen | 6525GA | Netherlands |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The target population consists of 1000 participants, equally distributed over different age groups (20-30, 30-40, 40-50, and 50-60 years old) and sex. Main exclusion criteria are any systemic condition or medication apart from cardiometabolic disorders, pregnancy at inclusion or recent vaccinations. Individuals will be compared over time, and age groups will be compared over time and per time point. None of the age groups will get an intervention, the goal is to observationally study them. |
|